PhD Postdoc Board Lunch Talk
1st April at 12:00-13:00
Onsite event
in Abo Lecture hall, 2nd floor BioCity
Maheswara Reddy Emani, Ph.D. Principal Scientist / Group Leader, Genentech, USA
Making a Difference to Patients: Careers with Purpose
Host: Rahul Biradar (rahul.biradar@utu.fi)
Registration link https://link.webropolsurveys.com/S/52DECECB404786F6
Organizer: Turku Bioscience Centre’s PhD-Postdoc Board
Mahesh earned his PhD in biotechnology from the National Center for Cell Sciences (NCCS) at the University of Pune, India, where his research focused on the role of cancer stem cells in brain tumors. This deeply inspired him to explore the fundamental biology of stem cells. Consequently, in 2010, he joined Professor Riitta Lehesmaa’s laboratory at Turku Biosciences in Turku, Finland, as a postdoctoral fellow. During his tenure there, he engaged in significant research projects that culminated in the identification and characterization of the novel pluripotency gene L1TD1, as well as its function in human embryonic stem cells and induced pluripotent stem cells (iPSCs). Subsequently, he joined Orion Pharma in Finland to leverage this technology in drug discovery, particularly utilizing iPS-directed differentiated target cells for drug discovery.
In 2017, he transitioned to the United States to join the Broad Institute of MIT and Harvard as a staff scientist. At the Broad Institute, his research concentrated on employing advanced stem cell technology and patient-derived kidney organoids to uncover the molecular mechanisms underlying epithelial cell injury and repair, with the goal of developing novel therapies for rare kidney diseases.
In 2020, Mahesh joined Genentech (a member of Roche) as a principal scientist and group leader, where he now leads his team on use of iPSC derived target cells and organoids for in vitro pharmacology. These tools proved invaluable for identifying promising lead molecules and conducting mechanistic and toxicological studies. He is thrilled to be part of an environment committed to conducting science at the highest level and transforming these scientific discoveries into therapeutic solutions that can significantly benefit patients.
